Large-scale testing (Phase 3)Study completedNCT04129398
What this trial is testing
MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042)
Who this might be right for
Cytomegalovirus InfectionCytomegalovirus Disease
Merck Sharp & Dohme LLC 22